• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • Our Team
  • What We Offer
    • Primary Care
    • Commercial
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • EMIS: Long Term Condition (LTC) Management
      • Medicine Management
        • EMIS: Precision Monitoring Template
        • EMIS: DMARDs and High Risk Drugs
        • EMIS: Safe Prescribing of Opioids / Opiates
      • Specialties
        • EMIS: Cancer
        • EMIS Cardiovascular Overview
          • EMIS: Cardiovascular Disease (AF, CHD, Hypertension)
          • EMIS: Cardiovascular Disease (CVD) Prevention
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • EMIS: Peripheral Arterial Disease Guide
        • EMIS Diabetes Overview
          • EMIS Diabetes
          • EMIS: Diabetes Technology
        • EMIS: Care for Frail Patients
        • EMIS: Haematology
        • Infection
          • EMIS: Infections Guide
          • EMIS: Blood Borne Virus (BBV)
        • EMIS: Learning Disabilities
        • EMIS: Neurology Guide
        • EMIS: NHS Health Checks
        • EMIS: Paediatric Assessment
        • EMIS Renal Overview
          • Chronic Kidney Disease (CKD) – EMIS
        • Respiratory Overview
          • EMIS Respiratory Resources
          • BeatAsthma+ Guide for EMIS
        • EMIS: Rheumatology
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Quality and Outcomes Framework (QOF) Guidance for 2023/24
        • SystmOne: NHS Health Checks
        • SystmOne: WorkWell Local Enhanced Service
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • SystmOne Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • SystmOne: Antibiotics Prescribing & Optimisation
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • SystmOne Heart Failure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes
          • SystmOne: Diabetes Technology
          • SystmOne Diabetic Kidney Disease
        • ENT Infections
        • Geriatrics Overview
          • SystmOne: Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Report Guide for SystmOne
          • Lipids Protocols
          • Lipid Management Templates
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care
        • SystmOne Renal/Urology Overview
          • Chronic Kidney Disease (CKD)
        • Respiratory Overview
          • Respiratory Resources
          • Respiratory Infections
        • Rheumatology Overview
          • SystmOne: Osteoporosis and Fragility Fractures
          • Bone Health
      • SystmOne: Weight Management
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
        • 6-8 Week Postnatal Check
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination SystmOne
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / Resources / EMIS Resource Centre / EMIS Specialties / EMIS Diabetes Overview / EMIS: Diabetes Technology

EMIS: Diabetes Technology

In collaboration with West Yorkshire Integrated Care Board (WYICB), CDRC has developed a comprehensive suite of reports to identify patients living with diabetes (all types) who may or may not be using specific diabetes medical-technology ((continuous glucose monitors (CGM), insulin pumps, hybrid closed loop (HCL) systems)). These reports can be used:

  1. To identify and prioritise the people most likely to benefit from diabetes med-tech to optimise their diabetes management at practice/PCN/sub-ICB and ICB level,
  2. As a population health management tool to monitor diabetes med-tech activity in line with national and local implementation plans and
  3. To support equity of access to diabetes med-technology.

Accessing the CDRC reports on EMIS

To access the CDRC Diabetes Technology Population Reporting Searches on EMIS, you will need to download and import the following .zip file:

CDRC Quality Diabetes Technology (13th May 2025)Download

As the operator of the CDRC, Health Innovation North East and North Cumbria Limited (on behalf of itself and/or its licensors) grants you a licence to copy and download this document in accordance with our terms of use. You must not modify the content of this document in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text. For further details, please see our terms of use (Terms of use – Clinical Digital Resource Collaborative (cdrc.nhs.uk)

If you have not performed this process before, please refer to the Download/ Import guide below, which provides you with step-by-step instructions on how to Download and Import .zip files into EMIS:

*NB: this guide uses a Lipid Resource File for illustrative purposes only, the steps undertaken to import the CDRC Quality Diabetes IGR file are the same.

EMIS Zip File Download and Import GuideDownload

You can check whether you have the most up-to-date version by reviewing the date on the .zip file. Any updates to the Population Reporting searches will be communicated to CDRC Precision users via the mailing list for the CDRC. To ensure you stay up to date with the latest information, please sign up to the mailing list at http://eepurl.com/9131L 

Guidance on the CDRC Diabetes Technology Reports

The reports are located in the CDRC Diabetes Technology > Diabetes Technology Focused Reports folder:

As you can see, there is a considerable number of reports in this folder. These reports have been grouped into the specific Diabetes Technologies for those coded with Type 1 and Type 2 / Other Diabetes in the clinical system. For each Diabetes Technology and Diabetes type, the reports are broken down further to highlight specific diabetes characteristics and demographic information, such as HbA1c level, number of Test Strip Prescriptions and Appointments; Ethnicity and Deprivation.

Population Health Data Analysis

To run all the reports in the Diabetes Technology folder,  right-click on the ” Diabetes Technology Focused Reports ” and select ‘Run‘.

This process may take a few minutes.

Once the reports have been run, highlight the Diabetes Technology Focused Reports and click View Results in the ribbon:

To export the results, select Export which will open the Export Report menu:

Select CSV and save the file to an appropriate place on your computer; You will now be able to edit the report within Excel.

Data Quality & Coding Improvements

WYICB worked with NHSE to get the following SNOMED codes added to the CT library – these codes are intended to support improved coding of diabetes technology in clinical records, inform diabetes clinical care and monitoring of diabetes med-tech access. Improved coding of diabetes med-technology use has the potential to support research and evaluation into the impact of diabetes med-technology on clinical outcomes and wellbeing in people living with diabetes.

The following codes should be used to improve med-technology coding accuracy, clinical safety associated with med-technology and ultimately the clinical care of your patients:

  • 1464561000000107 : Provision of continuous glucose monitoring system
  • 1464641000000105 : Continuous glucose monitoring stopped
  • 2242591000000104 : Provision of continuous subcutaneous insulin pump
  • 2242611000000107 : Automated delivery of insulin using continuous subcutaneous insulin pump stopped
  • 2242601000000105 : Provision of hybrid closed loop continuous automated insulin delivery system
  • 2242621000000101 : Automated delivery of insulin using hybrid closed loop system stopped

National Diabetes Audit (NDA) 2024-25 quarterly report for England

The NDA have released their quarterly report and there is a slight difference in the methods used by the NDA and CDRC to identify patients with Type 2 Diabetes using CGM.

NDA Type 2 diabetes/Other:

  • For those with type 2 diabetes, those who have any short acting insulin prescription who are recorded as on CGM over a 12 month reporting period are counted

CDRC:

  • For those with type 2 diabetes, those with any insulin drug on repeat or have a current insulin pump code who are recorded as on CGM are counted.

NDA Type 1 diabetes:

  • The NDA type 1 diabetes on CGM denominator is unrestricted and insulin type is not considered. 

The restriction of the NDA data set for CGM coverage in the type 1 diabetes population is that is only includes CGM that has been prescribed via FP10, not other CGM types accessed most often only via specialist diabetes services in secondary care.

The new SNOMED codes above have the potential to improve coding of med-technology use in the type 1 diabetes population within a person’s SystmOne electronic clinical record.

A link to the NDA report can be found here: https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/core-q4-24-25/national-diabetes-audit-nda-2024-25-quarterly-report-for-england-integrated-care-board-icb-primary-care-network-pcn-and-gp-practice(Edit)

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
contact-cdrc@healthinnovationnenc.org.uk
This website is operated by Health Innovation North East and North Cumbria. Suite A, 2nd Floor, 1 Citygate, Gallowgate, Newcastle upon Tyne NE1 4WH. Registered in England and Wales, Company Registration Number: 08727658
  • Terms of Reference
  • Privacy policy
  • Terms of use
  • Cookie Policy (UK)
  • Accessibility Statement

Copyright © 2025 Clinical Digital Resource Collaborative

Manage Consent
We use cookies to optimise our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}